Ewald H. Hettema

4.4k citations
51 papers · 3.6k indexed · h-index 31
Topics
Peroxisome Proliferator-Activated Receptors (37 papers)RNA Research and Splicing (18 papers)RNA modifications and cancer (16 papers)

In The Last Decade

Ewald H. Hettema

50 papers receiving 3.5k citations

Peers

Ewald H. Hettema
Comparison fields: 5 of 92
  • Molecular Biology 3.1k
  • Cell Biology 624
  • Epidemiology 602
  • Biochemistry 322
  • Physiology 292
Replace Ben Distel with:
Ben Distel Netherlands
Osamu Kuge Japan
Jun‐ichi Nikawa Japan
Jorge E. Azevedo Portugal
Masahide Oku Japan
Chaim Kahana Israel
Sidney V. Scott United States
Annetté Herscovics Canada
Ernst Jarosch Germany
Rosine Haguenauer‐Tsapis France
Ewald H. Hettema relative to Ben Distel Netherlands Ben Distel's profile →
Citations per field
00.5×1.6×
Ben Distel · 1×
Citations per year

Countries citing papers authored by Ewald H. Hettema

Since Specialization
Citations

This map shows the geographic impact of Ewald H. Hettema's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ewald H. Hettema with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ewald H. Hettema more than expected).

Fields of papers citing papers by Ewald H. Hettema

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ewald H. Hettema. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ewald H. Hettema. The network helps show where Ewald H. Hettema may publish in the future.

Co-authorship network of co-authors of Ewald H. Hettema

This figure shows the co-authorship network connecting the top 25 collaborators of Ewald H. Hettema. A scholar is included among the top collaborators of Ewald H. Hettema based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ewald H. Hettema. Ewald H. Hettema is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 1
3 1
4 0
5 3
6 31
7 109
8 60
9 53
10 90
11 53
12 208
13 124
14 171
15 264
16 94
17 14
18 116
19 21
20 14

About Ewald H. Hettema

Ewald H. Hettema is a scholar working on Molecular Biology, Aging and Cell Biology, having authored 51 papers that have together received 3.6k indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (37 papers), RNA Research and Splicing (18 papers) and RNA modifications and cancer (16 papers). The work is most often cited by research in Molecular Biology (3.1k citations), Biochemistry (322 citations) and Cell Biology (624 citations). Ewald H. Hettema has collaborated with scholars based in United Kingdom, Netherlands and Germany. Frequent co-authors include Alison M. Motley, Henk F. Tabak, Marlene van den Berg, Ben Distel, James M. Nuttall, Ronald J. A. Wanders, Carlo W.T. van Roermund, Dominic Hoepfner, Peter Philippsen and Marc Ouellette. Their work appears in journals such as Nature Genetics, The Journal of Cell Biology and The EMBO Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026